ArticleFrontiers in immunology2024

Efficacy and safety of atezolizumab-bevacizumab vs pembrolizumab-lenvatinib in unresectable hepatocellular carcinoma: a retrospective, cohort study.

Zili Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.